- Previous Close
69.90 - Open
69.80 - Bid 69.60 x 49300
- Ask 69.80 x 22000
- Day's Range
69.80 - 69.90 - 52 Week Range
47.15 - 70.40 - Volume
65 - Avg. Volume
2,196 - Market Cap (intraday)
1.207B - Beta (5Y Monthly) 0.85
- PE Ratio (TTM)
39.05 - EPS (TTM)
1.79 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 0.23 (0.33%)
- Ex-Dividend Date May 23, 2025
- 1y Target Est
70.00
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics. The company also provides human genetics, molecular pathology, HBOC, specialized laboratories, special diagnostics, gynecological hospital, ophthalmology, advanced reporting, MARIS healthcare GmbH, and ViREQ software solutions GmbH solutions for diagnostics. In addition, it offers radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions. Further, the company provides pathology, cytology, and laboratory solutions, as well as IT services comprising integrated solutions. NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany.
www.nexus-ag.de1,909
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NXU.DE
View MorePerformance Overview: NXU.DE
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NXU.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NXU.DE
View MoreValuation Measures
Market Cap
1.21B
Enterprise Value
1.11B
Trailing P/E
39.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.62
Price/Book (mrq)
4.32
Enterprise Value/Revenue
4.25
Enterprise Value/EBITDA
18.09
Financial Highlights
Profitability and Income Statement
Profit Margin
11.61%
Return on Assets (ttm)
4.88%
Return on Equity (ttm)
11.51%
Revenue (ttm)
265.52M
Net Income Avi to Common (ttm)
30.82M
Diluted EPS (ttm)
1.79
Balance Sheet and Cash Flow
Total Cash (mrq)
116.37M
Total Debt/Equity (mrq)
7.39%
Levered Free Cash Flow (ttm)
27.67M